International Journal of Drug Policy
Volume 18, Issue 2 , Pages 75-83 , March 2007

Strengthening drug policy and practice through ethics engagement: An old challenge for a new harm reduction

  • Kevin S. Irwin

      Affiliations

    • Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Suite 1B, Room 111, 40 Temple St., New Haven, CT 06510, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 203 764 4338; fax: +1 203 764 4353.
    • ,
  • Craig L. Fry

      Affiliations

    • Turning Point Alcohol and Drug Centre Inc., and Department of Public Health, University of Melbourne, Australia

Received 3 November 2006 ,Revised 1 December 2006 ,Accepted 5 December 2006.

References 

  1. Beauchamp TL, Childress J. Principles of biomedical ethics. New York: Oxford University Press; 1994;
  2. Beauchamp TL, Steinbock B. New ethics for the public's health. New York: Oxford University Press; 1999;
  3. Bell D. Communitarianism: From philosophy to politics. In:  Zalta EN editors. Stanford encyclopedia of philosophy. 2001;
  4. Biggs D, Blocker D. Foundations of ethical counselling. New York: Springer; 1987;
  5. Bourdieu P. The peculiar history of scientific reason. Sociological Forum. 1991;6(1):3–26
  6. Brody, B. A. (1998). The ethics of biomedical research: An international perspective: OUP.
  7. Buchanan D, Khoshnood K, Stopka T, Shaw S, Santicles C, Singer M. Ethical dilemmas created by the criminalization of status behaviors: Case examples from ethnographic field research with injection drug users. Health Education and Behavior. 2002;29(1):29–41
  8. Callahan D. Principlism and communitarianism. Journal of Medical Ethics. 2003;29(5):287–291
  9. Callahan D, Jennings B. Ethics and public health: Forging a strong relationship. American Journal of Public Health. 2002;92(2):169–176
  10. Campbell AV. The virtues (and vices) of the four principles. Journal of Medical Ethics. 2003;29(5):292–296
  11. Carter, L. (2002). A primer to ethical analysis. Office of Public Policy and Ethics: Institute for Molecular Bioscience, University of Queensland.
  12. Dorfman L, Wallack L, Woodruff K. More than a message: Framing public health advocacy to change corporate practices. Health Education and Behavior. 2005;32(3):320–336
  13. Erickson PG, Riley DM, Cheung YW, O’Hare PA. Harm reduction: A new direction for drug policies and programs. Toronto: University of Toronto Press; 1997;
  14. Fisher CB. Ethics in drug abuse and related HIV risk research. Applied Developmental Science. 2004;8(2):91–103
  15. Foot P. Virtues and vices. Oxford: Blackwell; 1978;
  16. Fry CL. Applied ethical reflections on the operation of a Geneva drug consumption room: Opportunities for enhanced harm reduction practice. International Journal of Drug Policy. 2006;17(1):1–2
  17. Fry C, Treloar C, Maher L. Ethical challenges and responses in harm reduction research: Promoting applied communitarian ethics. Drug and Alcohol Review. 2005;24(5):449–459
  18. Fry CL, Cvetkovski S, Cameron J. The place of supervised injecting facilities within harm reduction: Evidence, ethics and policy. Addiction. 2006;101(4):465–467
  19. Fry CL, Madden A, Brogan D, Loff B. Australian resources for ethical participatory processes in public health research. Journal of Medical Ethics. 2006;32(3):186
  20. Fry CL, Peerson A, Scully AM. Raising the profile of public health ethics in Australia: Time for debate. Australian and New Zealand Journal of Public Health. 2004;28:13–15
  21. Fulford KWM. Moral theory and medical practice. Cambridge: Cambridge University Press; 1989;
  22. Guillemin M, Gillam L. Telling moments: Everyday ethics in healthcare. Melbourne: IP Communications; 2006;
  23. Harris J. In praise of unprincipled ethics. Journal of Medical Ethics. 2003;29(5):303–306
  24. Hathaway AD. From harm reduction to human rights: Bringing liberalism back into drug reform debates. Drug and Alcohol Review. 2002;21(4):397–404
  25. Higgs P, Moore D, Aitken C. Engagement, reciprocity and advocacy: Ethical harm reduction practice in research with injecting drug users. Drug and Alcohol Review. 2006;25(5):419–423
  26. Hunt, N. (2003). A review of the evidence-base for harm reduction approaches to drug use. Forward Thinking on Drugs: http://www.forward-thinking-on-drugs.org/docs/Hunt-Harm-reduction-full.pdf.
  27. Hunt N. Public health or human rights: What comes first?. International Journal of Drug Policy. 2004;15(4):231–237
  28. Hunt N. Public health or human rights?. International Journal of Drug Policy. 2005;16:5–7
  29. IHRA. (2006). Harm reduction ethics committee. International Harm Reduction Association.
  30. Jennings, B., Kahn, J., Mastroianni, A., Parker L. S. (2003). Ethics and public health: Model Curriculum. Health Resources and Services Administration and the Association of Schools of Public Health.
  31. Keane H. Critiques of harm reduction, morality and the promise of human rights. International Journal of Drug Policy. 2003;14(3):227–232
  32. Kuhse H, Singer P. Bioethics: An anthology. Oxford: Blackwell Publishers; 1999;
  33. Levin BW, Fleischman AR. Public health and bioethics: The benefits of collaboration. American Journal of Public Health. 2002;92(2):165–167
  34. Loff B. Ethical challenges and responses in harm reduction research: A critique of applied communitarian ethics. Drug and Alcohol Review. 2006;25(4):371–372
  35. Lupton D. Risk as moral danger: The social and political functions of risk discourse in public health. International Journal of Health Services. 1993;23(3):425–435
  36. MacIntyre A. After virtue. London: Duckworth; 1981;
  37. Marlatt GA. Harm reduction: Come as you are. Addictive Behaviors. 1996;21(6):779–788
  38. McKeown RE, Weed DL. Ethics in epidemiology and public health II. Applied terms. Journal of Epidemiology and Community Health. 2002;56(10):739–741
  39. Nordenfelt, L. (1987). On the nature of health. Nordrecht: D. Reidel.
  40. O’Hare, P. (2006). What harm reduction means to me. International Harm Reduction Association.
  41. Phillips, R., Russell, C., Brennan, A. (2006). The value of diversity in the drug treatment sector? A study of values and their contribution to efficacious client outcomes. Poster presented at the17th International Conference on the Reduction of Drug Related Harm (p. 85), April 30–May 4, Vancouver, Canada. http://www.harmreduction2006.ca/pdf/hr_final_program.pdf.
  42. Porter J. Audience and rhetoric: An archaeological composition of the discourse community. New Jersey: Prentice Hall; 1992;
  43. Reinarman C. Public health and human rights: The virtues of ambiguity. International Journal of Drug Policy. 2004;15:239–241
  44. Roberts MJ, Reich MR. Ethical analysis in public health. Lancet. 2002;359(9311):1055–1059
  45. Rorty R. Contingency, irony, and social solidarity. New York: Cambridge University Press; 1989;
  46. Scholte JA. Globalization. A critical introduction. London: Palgrave; 2000;
  47. Seedhouse DF. Health: The foundations of achievement. Chichester: Wiley; 1986;
  48. Sherwin S. Foundations, frameworks, lenses: The role of theories in bioethics. Bioethics. 1999;13(3–4):198–205
  49. Siggins I. Professional codes: Some historical antecedents. In:  Coady M,  Bloch S editor. Codes of ethics and the professions. Carleton: MUP; 2002;p. 55–71
  50. Sindall C. Does health promotion need a code of ethics?. Health Promotion International. 2002;17:201–203
  51. Singer P. Practical ethics. Cambridge: Cambridge University Press; 1979;
  52. Solai S, Dubois-Arber F, Benninghoff F, Benaroyo L. Ethical reflections emerging during the activity of a low threshold facility with supervised drug consumption room in Geneva, Switzerland. International Journal of Drug Policy. 2006;17(1):17–22
  53. Somerville M. The ethical canary. Science, society and the human spirit. Viking: Penguin Books Australia, Ltd.; 2000;
  54. Stimson GV. Harm reduction in action: Putting theory into practice. International Journal of Drug Policy. 1998;9(6):401–409
  55. Thomas JC, Sage M, Dillenberg J, Guillory VJ. A code of ethics for public health. American Journal of Public Health. 2002;92(7):1057–1059
  56. Thompson A, Robertson A, Upshur R. Public health ethics: Towards a research agenda. Acta Bioethica. 2003;IX(2):157–163
  57. Turner L. Bioethics in pluralistic societies. Medicine, Health Care and Philosophy. 2004;7:201–208
  58. Van Den Brink W, Haasen C. Evidence-based treatment of opioid-dependent patients. Canadian Journal of Psychiatry. 2006;51(10):635–646
  59. White WL, Popovits RM. Critical incidents: Ethical issues in the prevention and treatment of addiction. Bloomington: Lighthouse Institute; 2001;
  60. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use and Misuse. 2006;41(6–7):777–813

PII: S0955-3959(06)00245-3

doi: 10.1016/j.drugpo.2006.12.002

International Journal of Drug Policy
Volume 18, Issue 2 , Pages 75-83 , March 2007

Article Tools